Midland Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Midland Wealth Advisors's BMY Position: Q2 2026 in Review
Midland Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,774 shares worth $333K. The position accounts for 0.02% of the portfolio, ranked #134.
Midland Wealth Advisors first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $891K in Q1 2024. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Midland Wealth Advisors held 5,774 shares of Bristol-Myers Squibb worth $333K as of Q2 2026.
- Midland Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.02% of Midland Wealth Advisors's portfolio in Q2 2026, its #134 holding.
- Midland Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Midland Wealth Advisors's Bristol-Myers Squibb position peaked at $891K in Q1 2024.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Midland Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.